Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Ganguli

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohortsWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohortMenayit Tamrat Dresse, Pamela C L Ferreira, Akshay Prasadan, et al.
Lancet (London, England)|April 25, 2006
Mild cognitive impairmentSerge Gauthier, Barry Reisberg, Michael Zaudig, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2016
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery FoundationHeather M Snyder, Tim Ahles, Stuart Calderwood, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 15, 2025
Association Between the Genetic Risk for Attention-Deficit/Hyperactivity Disorder and Cognitive Function in Older Age: The MYHAT Population-Based StudyDouglas Teixeira Leffa, Yingjin Zhang, Yueting Wang, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2024
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementiaAndrea M Weinstein, Fang Fang, Chung-Chou H Chang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumBeili Shao, Oluwatobi F Adeyemi, Penny Gowland, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's diseaseXuemei Zeng, Tara K Lafferty, Anuradha Sehrawat, et al.
Molecular Neurodegeneration|October 10, 2024
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's diseaseXuemei Zeng, Tara K Lafferty, Anuradha Sehrawat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 30, 2023
Umbrella review and Delphi study on modifiable factors for dementia risk reductionColin Rosenau, Sebastian Köhler, Lion M Soons, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohortsWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohortMenayit Tamrat Dresse, Pamela C L Ferreira, Akshay Prasadan, et al.
Lancet (London, England)|April 25, 2006
Mild cognitive impairmentSerge Gauthier, Barry Reisberg, Michael Zaudig, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2016
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery FoundationHeather M Snyder, Tim Ahles, Stuart Calderwood, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 15, 2025
Association Between the Genetic Risk for Attention-Deficit/Hyperactivity Disorder and Cognitive Function in Older Age: The MYHAT Population-Based StudyDouglas Teixeira Leffa, Yingjin Zhang, Yueting Wang, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2024
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementiaAndrea M Weinstein, Fang Fang, Chung-Chou H Chang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumBeili Shao, Oluwatobi F Adeyemi, Penny Gowland, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's diseaseXuemei Zeng, Tara K Lafferty, Anuradha Sehrawat, et al.
Molecular Neurodegeneration|October 10, 2024
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's diseaseXuemei Zeng, Tara K Lafferty, Anuradha Sehrawat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 30, 2023
Umbrella review and Delphi study on modifiable factors for dementia risk reductionColin Rosenau, Sebastian Köhler, Lion M Soons, et al.
Pageof 22